"The patient described in the paper had been diagnosed with three distinct conditions: autoimmune hemolytic anemia (AIHA), immune thrombocytopenia (ITP) and antiphospholipid antibody syndrome (APLAS)."
"Treating her with modified T-cells, however, has proven effective, with the patient's symptoms being absent more than a year after her treatment."
"[T]here's no cure other than treatment with long-term, high-dose steroids, and in this patient's case, steroids had not been effective."
CAR T therapy, initially developed for cancer treatment, has been successfully applied to autoimmune conditions. A recent case study details a patient with autoimmune hemolytic anemia, immune thrombocytopenia, and antiphospholipid antibody syndrome. After receiving CAR T therapy, the patient experienced significant improvement, with symptoms absent for over a year. Experts note that traditional treatments, such as long-term steroids, were ineffective for this patient. The success of this genetic therapy offers hope for future applications in treating similar conditions.
Read at InsideHook
Unable to calculate read time
Collection
[
|
...
]